Uninsured women not getting regular Pap smears

One-fourth of uninsured U.S. women between the ages of 18-64 reported not having had a Pap smear within the last three years when surveyed in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

This was double the 11 percent rate for women with private insurance and more than the 15 percent rate for women covered by Medicaid or any other public insurance.

The U.S. Preventive Services Task Force, which is sponsored by AHRQ, recommends that women from ages 21-64 receive a Pap smear screening every three years to detect cervical cancer and abnormal cells that can develop into cancer.

AHRQ data also shows that:

  • Overall, 14 percent of U.S. women age 18 to 64 – with or without insurance – did not receive a Pap smear within the last three years.
  • Asian women are more than twice as likely (21.5 percent ) to have not received a Pap smear in last three years than African American women (10 percent). White and Hispanic women fall in between (13.5 percent and 16 percent, respectively)
  • Women age 50-64 are nearly twice as likely (17 percent) to have not received a Pap smear compared to women ages 30-39 (9 percent). For women age 40-49 the rate is about 12 percent.

AHRQ, which is part of the U.S. Department of Health and Human Services, works to enhance the quality, safety, efficiency, and effectiveness of health care in the United States. The data in this AHRQ News and Numbers summary are taken from the Medical Expenditure Panel Survey, a highly detailed source of information on the health services used by Americans, how frequently they use them, the cost of those services, and how they are paid.

http://www.ahrq.gov/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Assessing the impact of gozetotide in PSMA-positive prostate cancer